A new spin on an old model - In vivo evaluation of disease progression by magnetic resonance imaging with respect to standard inflammatory parametersand histopathology in the adjuvant arthritic rat
Pb. Jacobson et al., A new spin on an old model - In vivo evaluation of disease progression by magnetic resonance imaging with respect to standard inflammatory parametersand histopathology in the adjuvant arthritic rat, ARTH RHEUM, 42(10), 1999, pp. 2060-2073
Objective. To noninvasively examine the pathogenesis of rat adjuvant-induce
d arthritis (AIA) by magnetic resonance imaging (MRI), and to correlate MRT
indices of disease progression with classic inflammatory parameters and hi
stologic evaluation.
Methods. AIA was established In male Lewis rats following subcutaneous inje
ction in the right hindpaw with 0.5 mg of heat-killed Mycobacteriun butyric
um suspended in light mineral oil, In vivo MRI evaluations of soft tissue a
nd bony changes in ALA rats with matched histopathology were correlated wit
h changes in left hindpaw volumes, circulating leukocytes, acute-phase reac
tants, and urinary collagen crosslinks throughout the disease process.
Results. MRI of arthritic tibiotarsal joints of the uninjected Left hindpaw
s from AIA rats demonstrated 2 distinct phases of disease activity. The fir
st phase, apparent between days 10 and 18, was characterized by periarticul
ar inflammation with marked synovitis, synovial fibroplasia, and distension
of the joint capsule into the surrounding tissue. The secondary phase, occ
urring between days 18 and 30, was marked by continued soft tissue inflamma
tion, periostitis with osteolysis, and periosteal new bone formation progre
ssing to a state of near complete ankylosis by day 30, These 2 phases of di
sease activity observed by MRI paralleled biochemical, cellular, and histol
ogic markers of disease progression,
Conclusion. MRI can be used to noninvasively detect, monitor, and quantify
the chronic synovitis and progressive destruction of soft tissue and bone i
n live AIA rats, thereby improving the ability to evaluate disease progress
ion in this preclinical animal model of rheumatoid arthritis.